Results 161 to 170 of about 6,942 (191)
Dihydroartemisinin–piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study [PDF]
Lancet Infectious Diseases, The, 2016 Artemisinin resistance in Plasmodium falciparum threatens to reduce the efficacy of artemisinin combination therapies (ACTs), thus compromising global efforts to eliminate malaria.
Roberto Amato +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Dihydroartemisinin/Piperaquine
Drugs, 2012Artemisinin-based combination regimens are recommended by WHO for the treatment of uncomplicated Plasmodium falciparum malaria. One such combination comprises the artemisinin derivative dihydroartemisinin and the bisquinolone piperaquine. Eurartesim® is the only dihydroartemisinin/piperaquine formulation that meets international good manufacturing ...
openaire +2 more sources
Dihydroartemisinin/Piperaquine for the treatment of uncomplicated P. falciparum malaria
201010. Kongress für Infektionskrankheiten und Tropenmedizin (KIT 2010)
openaire +2 more sources